CID 5284514

Acrivastine

Structural Information

Molecular Formula
C22H24N2O2
SMILES
CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O
InChI
InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+
InChIKey
PWACSDKDOHSSQD-IUTFFREVSA-N
Compound name
(E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid
Related CIDs

2D Structure

compound 2d structure
8
Annotation Hits

83
References

14873
Patents

348.18378 Da
Monoisotopic Mass

1.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 349.19106 186.9
[M+Na]+ 371.17300 190.7
[M-H]- 347.17650 191.6
[M+NH4]+ 366.21760 197.5
[M+K]+ 387.14694 184.1
[M+H-H2O]+ 331.18104 176.7
[M+HCOO]- 393.18198 202.6
[M+CH3COO]- 407.19763 209.5
[M+Na-2H]- 369.15845 184.1
[M]+ 348.18323 183.2
[M]- 348.18433 183.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe